IFNG and cancer: An increase in interferon (IFN)-γ-producing T helper (Th)1 cells has been recognized as an antitumour immune signature in cancer patients5, 7, because favourable prognosis is closely correlated with high expression of Th1-related genes, Ifng and Tbx21 (T-bet)5.